Industry Trends

Webinar Date/Time: Tue, Sep 26, 2023 10:00 AM EDT | 9:00 AM CT | 3:00 PM BST | 4:00 PM CEST

Here at Pharmaceutical Executive®, we are already planning our editorial calendar for 2024. And each year we go through this process, I consider this a time of reflection to see where the industry has come, what topics always seem to be on the tips of everyone’s tongues, and what should be a topic of focus. Along with artificial intelligence (AI) being top of mind, other topics that come into my inbox again and again relate to diversity, equity, and inclusion (DE&I) and addressing unmet medical needs.

The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.

Webinar Date/Time: Thu, May 18, 2023 11:00 AM EDT

Webinar Date/Time: Wednesday, May 24th, 2023 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform.

After the pandemic forced fundamenta­l­­­­ changes in the ways pharma and key opinion leaders worked together, both groups are using what they learned for a more seamless connection.

Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data.

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes that impact Medicare, as well as the Foundation's near-term goals.

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes to Medicare and how it positively effects patients.

At Pharma USA 2023, Peter Marks, MD, PhD and director of CBER described FDA and public/private partnerships working toward scalable manufacturing approaches to address commercial viability and global access for cell and gene therapies

As the life sciences industry enters this next stage of growth, capitalizing on AI and digital transformation will be key to propelling innovation and ensuring that companies are prepared to tackle the challenges ahead.

How pharma companies can leverage the lessons learned during the pandemic around key opinion leaders and digital opinion leaders, respectively, to best use new channels of communication. Can both coexist across the healthcare engagement spectrum?

Webinar Date/Time: Wed, Apr 12, 2023 1:00 PM EDT

Webinar Date/Time: Mon, Mar 13, 2023 11:00 AM EDT

Webinar Date/Time: Thu, Mar 16, 2023 11:00 AM EDT

Delivering value with enterprise program management.

What the c-suite should consider in today’s marketplace.

As they are forced to do more with less, pharma commercial leaders should rethink their incentive programs to ensure their sales teams remain strong drivers of growth.

Pharma companies are teaming with academic institutions earlier in the R&D process.

Interpreting what the Inflation Reduction Act could mean for biopharma.

How technology will play a big role in advancing pharma approaches in patient support.

As new channels enter healthcare conversation mix, engagement strategies are changing.

An evolving job market has forced life sciences companies to respond.

The steps companies can take now to better protect themselves and their data.

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

Personalized medicine continued its growth over the past year and became one of the most talked about topics in the life sciences industry.

Top industry experts weigh in on what the new year holds for the pharma industry.

Over the past year, the life sciences industry has experienced a variety of important innovations, while also facing an unstable economy. These factors were clearly on readers minds and helped shape the top stories of the year.

Michael Ku, VP of global clinical supply at Pfizer, shares insights for the c-suite as well as reveals behind-the-scenes insight into Pfizer’s ability to deliver a COVID-19 vaccine swiftly.